Voltaren Arthritis Pain Gel: OTC relief for aching joints

Voltaren Arthritis Pain Gel is a topical NSAID designed to relieve joint pain directly at the source, available over the counter in the US without a prescription.

Responsible: ad hoc news Classics & Long-sellers Desk. Reviewed prior to publication on June 14, 2026 at 5:15 PM ET. Details in the imprint.

Voltaren Arthritis Pain Gel has become a staple on US pharmacy shelves for people looking to manage osteoarthritis pain without a prescription. The over-the-counter topical NSAID is formulated with 1% diclofenac sodium and is indicated for arthritis pain in joints such as hands, wrists, elbows, knees, ankles, and feet. It is marketed in the US by Haleon, the consumer health company that was spun out of GSK PLC and holds rights to the Voltaren brand in many markets.

Unlike traditional oral painkillers, Voltaren Arthritis Pain Gel is applied directly to the skin over the affected joint, where it is absorbed and works as a nonsteroidal anti-inflammatory drug to reduce pain and inflammation. The product is FDA-approved for over-the-counter use for arthritis pain, having switched from prescription status to OTC in the US in 2020, which significantly broadened its reach among consumers who prefer self-care solutions.

How Voltaren Arthritis Pain Gel works and who it is for

Voltaren Arthritis Pain Gel is designed specifically for adults with osteoarthritis or arthritis-related joint pain, not for strains, sprains, or bruises. According to the official product information from Haleon, the active ingredient diclofenac sodium 1% penetrates the skin to deliver an NSAID effect in the tissues around the joint, inhibiting cyclooxygenase (COX) enzymes and reducing production of prostaglandins associated with pain and inflammation. The gel is fragrance-free, which appeals to users who are sensitive to strong scents in topical products.

The recommended dosing schedule in the US is up to four times a day for affected joints, with the amount of gel measured using a dosing card included in the package. Consumers are instructed not to use more than directed, not to use it on more than two body areas at the same time, and not to use it for more than 21 days unless directed by a doctor. These directions are aimed at managing systemic exposure to diclofenac and aligning the OTC product with safety standards established during its time as a prescription medicine.

Voltaren Arthritis Pain Gel is available in several tube and pump sizes on the US market, commonly including 1.76 oz, 3.5 oz, and larger economy sizes that are distributed through major retailers. In US drugstores and mass retailers, list prices often range from around $10 to $30 depending on size and promotional discounts, though actual shelf prices vary by chain and region based on retailer pricing policies and sales campaigns. The product is widely stocked at chains such as CVS, Walgreens, Walmart, Target, and also via online marketplaces where Haleon and retail partners handle distribution.

Because Voltaren is classified as an NSAID, the product carries standard warnings similar to oral NSAIDs, including cautions about potential stomach bleeding, cardiovascular risks, and the need to consult a doctor for patients with high blood pressure, heart disease, liver or kidney disease, or those taking blood thinners. Pregnant women, especially in the last trimester, are advised not to use the gel unless directed by a health professional. These warnings reinforce that, although the product is topical and OTC, it is a pharmacologically active medicine rather than a simple cosmetic cream.

For many consumers with mild to moderate osteoarthritis pain, Voltaren Arthritis Pain Gel offers an alternative to constantly taking oral NSAIDs or acetaminophen. The gel format can be especially attractive for older adults who already take multiple oral medications and prefer to limit additional pills. Reviews from US users on retailer platforms frequently highlight perceived benefits such as improved mobility in fingers and knees, though experiences vary and some users report limited relief, underlining that individual response to topical NSAIDs can differ.

Haleon and GSK have emphasized Voltaren as one of the key brands in their pain-relief portfolio, alongside other consumer names. Within the broader GSK ecosystem, consumer health brands like Voltaren were transferred into Haleon, while GSK PLC retained its focus on prescription medicines and vaccines. The continued strength of Voltaren in markets such as the US supports Haleon’s consumer health revenues, while GSK benefits from the structure established during the spin-off and its ongoing interest in consumer brands through historic ties. Shares of GSK PLC (GB0009252882, ticker GSK) traded at $53.04 on the NYSE on June 14, 2026.

Voltaren Arthritis Pain Gel at a glance

• Product: Voltaren Arthritis Pain Gel
• Manufacturer: GSK PLC
• Category: classic / long-seller
• Launch date: Prescription formulation approved earlier; US OTC switch in 2020 (arthritis pain indication)
• MSRP / Price: Typically around $10 to $30 in the US for common pack sizes, depending on retailer promotions (as of June 2026)
• Availability: Widely available in the US at major drugstores, mass retailers, and online channels
• Target audience: Adults seeking nonprescription relief from osteoarthritis-related joint pain
• Key feature / USP: Topical 1% diclofenac NSAID gel that targets arthritis pain directly at the joint

This article was created with a.i. assistance and editorially reviewed. Product information is provided without warranty; prices and availability may change at any time. Not investment advice, not a buy or sell recommendation. Trading in securities carries risks up to the total loss of capital.